These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 30225558)
1. Survival rate, causes of death, and risk factors in systemic sclerosis: a large cohort study. Li X; Qian YQ; Liu N; Mu R; Zuo Y; Wang GC; Jia Y; Li ZG Clin Rheumatol; 2018 Nov; 37(11):3051-3056. PubMed ID: 30225558 [TBL] [Abstract][Full Text] [Related]
2. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status. Simeón-Aznar CP; Fonollosa-Plá V; Tolosa-Vilella C; Espinosa-Garriga G; Ramos-Casals M; Campillo-Grau M; García-Hernández FJ; Castillo-Palma MJ; Sánchez-Román J; Callejas-Rubio JL; Ortego-Centeno N; Egurbide-Arberas MV; Trapiellla-Martínez L; Gallego-Villalobos M; Sáez-Comet L; Velilla-Marco J; Camps-García MT; de Ramón-Garrido E; Esteban Marcos EM; Pallarés-Ferreres L; Hidalgo-Tenorio C; Sabio-Sánchez JM; Gómez-de la Torre R; Salvador-Cervello G; Rios-Blanco JJ; Gil-Aguado A; Vilardell-Tarrés M Semin Arthritis Rheum; 2012 Jun; 41(6):789-800. PubMed ID: 22169458 [TBL] [Abstract][Full Text] [Related]
3. Determinants of morbidity and mortality of systemic sclerosis in Canada. Al-Dhaher FF; Pope JE; Ouimet JM Semin Arthritis Rheum; 2010 Feb; 39(4):269-77. PubMed ID: 18706680 [TBL] [Abstract][Full Text] [Related]
4. Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group. Sánchez-Cano D; Ortego-Centeno N; Callejas JL; Fonollosa Plá V; Ríos-Fernández R; Tolosa-Vilella C; Espinosa-Garriga G; Colunga-Argüelles D; Egurbide-Arberas MV; Rubio-Rivas M; Freire M; Ríos-Blanco JJ; Trapiella-Martínez L; Rodríguez-Carballeira M; Marín-Ballvé A; Pla-Salas X; Simeón-Aznar CP Rheumatol Int; 2018 Mar; 38(3):363-374. PubMed ID: 29322341 [TBL] [Abstract][Full Text] [Related]
5. Survival and causes of death in an unselected and complete cohort of Norwegian patients with systemic sclerosis. Hoffmann-Vold AM; Molberg Ø; Midtvedt Ø; Garen T; Gran JT J Rheumatol; 2013 Jul; 40(7):1127-33. PubMed ID: 23637316 [TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease. Launay D; Humbert M; Berezne A; Cottin V; Allanore Y; Couderc LJ; Bletry O; Yaici A; Hatron PY; Mouthon L; Le Pavec J; Clerson P; Hachulla E Chest; 2011 Oct; 140(4):1016-1024. PubMed ID: 21474572 [TBL] [Abstract][Full Text] [Related]
7. Registry of the Spanish Network for Systemic Sclerosis: Survival, Prognostic Factors, and Causes of Death. Simeón-Aznar CP; Fonollosa-Plá V; Tolosa-Vilella C; Espinosa-Garriga G; Campillo-Grau M; Ramos-Casals M; García-Hernández FJ; Castillo-Palma MJ; Sánchez-Román J; Callejas-Rubio JL; Ortego-Centeno N; Egurbide-Arberas MV; Trapiellla-Martínez L; Caminal-Montero L; Sáez-Comet L; Velilla-Marco J; Camps-García MT; de Ramón-Garrido E; Esteban-Marcos EM; Pallarés-Ferreres L; Navarrete-Navarrete N; Vargas-Hitos JA; Torre RG; Salvador-Cervello G; Rios-Blanco JJ; Vilardell-Tarrés M; Medicine (Baltimore); 2015 Oct; 94(43):e1728. PubMed ID: 26512564 [TBL] [Abstract][Full Text] [Related]
8. Digital ulcers and cutaneous subsets of systemic sclerosis: Clinical, immunological, nailfold capillaroscopy, and survival differences in the Spanish RESCLE Registry. Tolosa-Vilella C; Morera-Morales ML; Simeón-Aznar CP; Marí-Alfonso B; Colunga-Arguelles D; Callejas Rubio JL; Rubio-Rivas M; Freire-Dapena M; Guillén-Del Castillo A; Iniesta-Arandia N; Castillo-Palma MJ; Egurbide-Arberas M; Trapiellla-Martínez L; Vargas-Hitos JA; Todolí-Parra JA; Rodriguez-Carballeira M; Marin-Ballvé A; Pla-Salas X; Rios-Blanco JJ; Fonollosa-Pla V; Semin Arthritis Rheum; 2016 Oct; 46(2):200-208. PubMed ID: 27312381 [TBL] [Abstract][Full Text] [Related]
9. Prognostic profile of systemic sclerosis: analysis of the clinical EUSTAR cohort in China. Hu S; Hou Y; Wang Q; Li M; Xu D; Zeng X Arthritis Res Ther; 2018 Oct; 20(1):235. PubMed ID: 30348207 [TBL] [Abstract][Full Text] [Related]
10. Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease. Mathai SC; Hummers LK; Champion HC; Wigley FM; Zaiman A; Hassoun PM; Girgis RE Arthritis Rheum; 2009 Feb; 60(2):569-77. PubMed ID: 19180517 [TBL] [Abstract][Full Text] [Related]
11. Impact of Systemic Sclerosis-Associated Interstitial Lung Disease With and Without Pulmonary Hypertension on Survival: A Large Cohort Study of the German Network for Systemic Sclerosis. Moinzadeh P; Bonella F; Oberste M; Weliwitage J; Blank N; Riemekasten G; Müller-Ladner U; Henes J; Siegert E; Günther C; Kötter I; Pfeiffer C; Schmalzing M; Zeidler G; Korsten P; Susok L; Juche A; Worm M; Jandova I; Ehrchen J; Sunderkötter C; Keyßer G; Ramming A; Schmeiser T; Kreuter A; Lorenz HM; Hunzelmann N; Kreuter M Chest; 2024 Jan; 165(1):132-145. PubMed ID: 37582424 [TBL] [Abstract][Full Text] [Related]
12. High Prevalence of Acute Exacerbation of Interstitial Lung Disease in Japanese Patients with Systemic Sclerosis. Tomiyama F; Watanabe R; Ishii T; Kamogawa Y; Fujita Y; Shirota Y; Sugimura K; Fujii H; Harigae H Tohoku J Exp Med; 2016 Aug; 239(4):297-305. PubMed ID: 27487743 [TBL] [Abstract][Full Text] [Related]
13. Survival and causes of death in systemic sclerosis patients: a single center registry report from Iran. Poormoghim H; Andalib E; Jalali A; Ghaderi A; Ghorbannia A; Mojtabavi N Rheumatol Int; 2016 Jul; 36(7):925-34. PubMed ID: 27061806 [TBL] [Abstract][Full Text] [Related]
14. Interstitial lung disease increases mortality in systemic sclerosis patients with pulmonary arterial hypertension without affecting hemodynamics and exercise capacity. Michelfelder M; Becker M; Riedlinger A; Siegert E; Drömann D; Yu X; Petersen F; Riemekasten G Clin Rheumatol; 2017 Feb; 36(2):381-390. PubMed ID: 28028682 [TBL] [Abstract][Full Text] [Related]
15. Mortality in the Waikato Hospital Systemic Sclerosis Cohort. Ooi C; Solanki K; Lao C; Frampton C; White D Int J Rheum Dis; 2018 Jan; 21(1):253-260. PubMed ID: 28580628 [TBL] [Abstract][Full Text] [Related]
16. Mortality and hospitalization outcomes of interstitial lung disease and pulmonary hypertension in the Singapore systemic sclerosis cohort. Noviani M; Saffari SE; Tan JL; Yip JWL; Teng GG; Law WG; Chan GYL; Santosa A; Lim AYN; Hong C; Ng SA; Tay ELW; Ruan W; Yap J; Low AHL Semin Arthritis Rheum; 2020 Jun; 50(3):473-479. PubMed ID: 31810742 [TBL] [Abstract][Full Text] [Related]
17. Prediction of pulmonary complications and long-term survival in systemic sclerosis. Nihtyanova SI; Schreiber BE; Ong VH; Rosenberg D; Moinzadeh P; Coghlan JG; Wells AU; Denton CP Arthritis Rheumatol; 2014 Jun; 66(6):1625-35. PubMed ID: 24591477 [TBL] [Abstract][Full Text] [Related]
19. Lung and gastrointestinal complications are leading causes of death in SCORE, a multi-ethnic Singapore systemic sclerosis cohort. Santosa A; Tan CS; Teng GG; Fong W; Lim A; Law WG; Chan G; Ng SC; Low A Scand J Rheumatol; 2016 Nov; 45(6):499-506. PubMed ID: 27232525 [TBL] [Abstract][Full Text] [Related]